Report

1 INTRODUCTION 58
1.1 STUDY OBJECTIVES 58
1.2 MARKET DEFINITION 58
1.3 STUDY SCOPE 59
1.3.1 MARKETS COVERED 59
1.3.2 INCLUSIONS & EXCLUSIONS 60
1.3.3 YEARS CONSIDERED 63
1.4 CURRENCY CONSIDERED 64
1.5 STAKEHOLDERS 64
2 RESEARCH METHODOLOGY 65
2.1 RESEARCH DATA 65
2.1.1 SECONDARY DATA 66
2.1.1.1 Key data from secondary sources 67
2.1.2 PRIMARY DATA 67
2.1.2.1 Key industry insights 69
2.2 MARKET SIZE ESTIMATION 70
2.3 DATA TRIANGULATION 76
2.4 MARKET SHARE ESTIMATION 77
2.5 STUDY ASSUMPTIONS 77
2.6 LIMITATIONS 77
2.6.1 METHODOLOGY-RELATED LIMITATIONS 77
2.6.2 SCOPE-RELATED LIMITATIONS 77
2.7 RISK ASSESSMENT 78
3 EXECUTIVE SUMMARY 79
4 PREMIUM INSIGHTS 85
4.1 AI IN HEALTHCARE MARKET OVERVIEW 85
4.2 ASIA PACIFIC: AI IN HEALTHCARE, BY OFFERING AND COUNTRY 86
4.3 AI IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 87
4.4 AI IN HEALTHCARE MARKET: REGIONAL MIX 87
4.5 AI IN HEALTHCARE: DEVELOPED VS. EMERGING MARKETS 88
5 MARKET OVERVIEW 89
5.1 INTRODUCTION 89
5.2 MARKET DYNAMICS 89
5.2.1 DRIVERS 90
5.2.1.1 Increase in need for early detection and diagnosis 90
5.2.1.2 Exponential growth in data volume and complexity due to surging adoption of digital technologies 91
5.2.1.3 Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases 91
5.2.1.4 Rapid proliferation of AI in healthcare sector 92
5.2.1.5 Growth in need for improvised healthcare services 93
5.2.2 RESTRAINTS 93
5.2.2.1 Reluctance among medical practitioners to adopt AI-based technologies 93
5.2.2.2 Shortage of skilled AI professionals handling AI-powered solutions 94
5.2.2.3 Lack of standardized frameworks for AI and ML technologies 94
5.2.3 OPPORTUNITIES 95
5.2.3.1 Increasing use of AI-powered solutions in elderly care 95
5.2.3.2 Increase in focus on developing human-aware AI systems 95
5.2.3.3 Strategic partnerships and collaborations among healthcare companies and AI technology providers 96
5.2.4 CHALLENGES 97
5.2.4.1 Inaccurate predictions due to scarcity of high-quality healthcare data 97
5.2.4.2 Concerns regarding data privacy 98
5.2.4.3 Lack of interoperability between AI solutions offered by different vendors 99
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 100
5.4 TECHNOLOGY ANALYSIS 101
5.4.1 KEY TECHNOLOGIES 101
5.4.1.1 Machine learning (ML) and deep learning 101
5.4.1.2 Natural language processing (NLP) 101
5.4.1.3 Computer vision (CV) 101
5.4.2 COMPLEMENTARY TECHNOLOGIES 102
5.4.2.1 Cloud computing 102
5.4.2.2 Digital twins 102
5.4.2.3 Robotic process automation (RPA) 102
5.4.3 ADJACENT TECHNOLOGIES 102
5.4.3.1 Blockchain 102
5.4.3.2 Augmented and virtual reality (AR/VR) 103
5.4.3.3 Internet of things (IoT) 103
5.5 INDUSTRY TRENDS 103
5.5.1 SHIFT TOWARD PERSONALIZED MEDICINE 103
5.5.2 AI IN DIAGNOSTICS AND IMAGING 104
5.6 PRICING ANALYSIS 104
5.6.1 INDICATIVE PRICING OF AI IN HEALTHCARE SOFTWARE, BY DEPLOYMENT MODEL (QUALITATIVE) 105
5.6.2 INDICATIVE PRICING OF AI IN HEALTHCARE SOFTWARE, BY REGION (QUALITATIVE) 105
5.7 VALUE CHAIN ANALYSIS 106
5.8 ECOSYSTEM ANALYSIS 107
5.9 PATENT ANALYSIS 110
5.9.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 110
5.10 KEY CONFERENCES & EVENTS 114
5.11 CASE STUDY ANALYSIS 115
5.11.1 BIOBEAT LAUNCHED HOME-BASED REMOTE PATIENT MONITORING KIT DURING PEAK WAVE OF COVID-19 115
5.11.2 MICROSOFT COLLABORATED WITH CLEVELAND CLINIC TO APPLY PREDICTIVE AND ADVANCED ANALYTICS TO IDENTIFY POTENTIAL AT-RISK PATIENTS UNDER ICU CARE 116
5.11.3 TGEN COLLABORATED WITH INTEL CORPORATION AND DELL TECHNOLOGIES TO ASSIST PHYSICIANS AND RESEARCHERS IN ACCELERATING DIAGNOSIS AND TREATMENT AT LOWER COSTS 116
5.11.4 GE HEALTHCARE IMPROVED PATIENT OUTCOMES BY REDUCING WORKFLOW PROCESSING TIME USING MEDICAL IMAGING DATA 117
5.12 REGULATORY LANDSCAPE 117
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 117
5.12.2 REGULATORY FRAMEWORK 120
5.12.2.1 North America 120
5.12.2.2 Europe 122
5.12.2.3 Asia Pacific 122
5.12.2.4 Middle East & Africa 123
5.12.2.5 Latin America 124
5.13 PORTER'S FIVE FORCES ANALYSIS 124
5.13.1 THREAT OF NEW ENTRANTS 125
5.13.2 THREAT OF SUBSTITUTES 126
5.13.3 BARGAINING POWER OF SUPPLIERS 126
5.13.4 BARGAINING POWER OF BUYERS 126
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 126
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 127
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 127
5.14.2 BUYING CRITERIA 128
5.15 END-USER ANALYSIS 129
5.15.1 UNMET NEEDS 129
5.15.2 END-USER EXPECTATIONS 130
5.16 AI IN HEALTHCARE BUSINESS MODELS 131
5.16.1 SOFTWARE-AS-A-SERVICE (SAAS) MODEL 131
5.16.2 LICENSING MODEL 131
5.16.3 REVENUE SHARING/OUTCOME-BASED MODEL 131
5.16.4 FREEMIUM MODEL 131
5.16.5 AI-AS-A-SERVICE (AIAAS) MODEL 131
5.16.6 PARTNERSHIP/REVENUE-SHARING MODEL 132
5.16.7 HYBRID MODELS 132
5.16.8 PAY-PER-USE MODELS 132
5.17 INVESTMENT & FUNDING SCENARIO 132
5.18 IMPACT OF GENERATIVE AI ON AI IN HEALTHCARE MARKET 133
5.18.1 INTRODUCTION 133
5.18.2 MARKET POTENTIAL OF GEN AI IN HEALTHCARE 133
5.18.2.1 Key use cases of Gen AI 134
5.18.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 135
5.18.3.1 Eka Care leveraging generative AI for improved health outcomes 135
5.18.4 INTERCONNECTED AND ADJACENT ECOSYSTEMS 136
5.18.4.1 AI in healthcare IT 137
5.18.4.2 AI in medical diagnostics 137
5.18.4.3 AI in oncology 138
5.18.4.4 AI in clinical trials 138
5.18.4.5 AI in drug discovery 138
5.18.5 USER READINESS & IMPACT ASSESSMENT 139
5.18.5.1 User readiness 139
5.18.5.1.1 Healthcare providers 139
5.18.5.1.2 Healthcare payers 139
5.18.5.1.3 Patients 139
5.18.5.2 Impact assessment 140
5.18.5.2.1 User A: Healthcare providers 140
5.18.5.2.1.1 Implementation 140
5.18.5.2.1.2 Impact 140
5.18.5.2.2 User B: Healthcare payers 140
5.18.5.2.2.1 Implementation 140
5.18.5.2.2.2 Impact 141
5.18.5.2.3 User C: Patients 141
5.18.5.2.3.1 Implementation 141
5.18.5.2.3.2 Impact 141
6 IMPACT OF 2025 US TARIFF - OVERVIEW 142
6.1 INTRODUCTION 142
6.2 KEY TARIFF RATES 142
6.3 PRICE IMPACT ANALYSIS 143
6.4 IMPACT ON COUNTRY/REGION 144
6.4.1 US 144
6.4.2 EUROPE 145
6.4.3 ASIA PACIFIC 145
6.5 IMPACT ON END-USE INDUSTRIES 146
?
7 AI IN HEALTHCARE MARKET, BY OFFERING 147
7.1 INTRODUCTION 148
7.2 INTEGRATED SOLUTIONS 148
7.2.1 RISE IN WORKFORCE CHALLENGES AND COST PRESSURES TO DRIVE ADOPTION 148
7.3 NICHE/POINT SOLUTIONS 149
7.3.1 TARGETED AI SOLUTIONS TRANSFORMING PRECISION CARE AND EFFICIENCY IN HEALTHCARE TO BOOST MARKET 149
7.4 AI TECHNOLOGIES 150
7.4.1 ABILITY OF CORE AI TECHNOLOGIES TO DRIVE PRECISION, EFFICIENCY, AND INNOVATION TO SUPPORT MARKET GROWTH 150
7.5 SERVICES 151
7.5.1 NEED TO EMPOWER NON-CLINICAL HEALTHCARE OPERATIONS TO FUEL MARKET GROWTH 151
8 AI IN HEALTHCARE MARKET, BY FUNCTION 153
8.1 INTRODUCTION 154
8.2 DIAGNOSIS & EARLY DETECTION 154
8.2.1 PRE-SCREENING 156
8.2.1.1 Early detection, better outcomes, and cost-effective care associated with pre-screening to boost market 156
8.2.2 IVD 156
8.2.2.1 IVD market, by technology 157
8.2.2.1.1 Immunoassays 158
8.2.2.1.1.1 Increase in focus on earlier disease detection & personalized treatment planning to drive market 158
8.2.2.1.2 Clinical chemistry 158
8.2.2.1.2.1 Increased demand for precision and personalized medicine and efficient healthcare systems to drive market 158
8.2.2.1.3 Molecular diagnostics 159
8.2.2.1.3.1 Improved disease detection, personalized treatments, and enhanced outcomes to fuel growth 159
8.2.2.2 IVD market, by application 160
8.2.2.2.1 Image analysis & interpretation 160
8.2.2.2.1.1 Advantages such as enhanced diagnostic accuracy, faster detection, and improved patient outcomes to support growth 160
8.2.2.2.2 Biomarker discovery & analysis 161
8.2.2.2.2.1 Ability of AI-based biomarker discovery to enhance disease detection, prognosis, and personalized treatment to drive adoption 161
8.2.2.2.3 Other IVD applications 162
8.2.3 DIAGNOSTIC IMAGING 162
8.2.3.1 Diagnostic imaging market, by application 163
8.2.3.1.1 Disease interpretation & report analysis 164
8.2.3.1.1.1 Ability of AI-driven disease interpretation to accelerate diagnosis, treatment, and outcomes to fuel growth 164
8.2.3.1.2 Image captioning & annotation 164
8.2.3.1.2.1 Enhanced diagnostic accuracy, efficiency, and consistency associated with image captioning & annotation to boost market 164
8.2.3.1.3 Image reconstruction 165
8.2.3.1.3.1 Improved diagnostic precision, efficiency, and image quality in healthcare to drive market 165
8.2.3.1.4 Other diagnostic imaging applications 166
8.2.3.2 Diagnostic imaging market, by modality 166
8.2.3.2.1 Magnetic resonance imaging (MRI) 167
8.2.3.2.1.1 Rise in technological advancements to drive adoption of AI in MRI 167
8.2.3.2.2 Computed tomography (CT) 168
8.2.3.2.2.1 Increase in availability of cardiac CT devices enabled with AI solutions to drive market 168
8.2.3.2.3 X-ray imaging 169
8.2.3.2.3.1 Innovative AI solutions for X-ray imaging by key players to drive market 169
8.2.3.2.4 Ultrasound 170
8.2.3.2.4.1 Increase in prevalence of and need for early detection of ovarian cancer to drive market 170
8.2.3.2.5 Nuclear imaging (PET & SPECT) 171
8.2.3.2.5.1 Critical role played by PET and SPECT in visualizing metabolic processes to contribute to growth 171
8.2.3.2.6 Other diagnostic imaging modalities 171
8.2.4 RISK ASSESSMENT & PATIENT STRATIFICATION 172
8.2.4.1 AI-driven risk assessment and patient stratification to enhance healthcare efficiency, outcomes, and personalized care 172
8.2.5 DRUG ALLERGY ALERTING 173
8.2.5.1 Ability of AI-enhanced drug allergy alerting to improve accuracy and patient safety to boost market 173
8.2.6 OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS 174
8.3 TREATMENT PLANNING & PERSONALIZATION 175
8.3.1 PERSONALIZED TREATMENT PLANNING 176
8.3.1.1 Precision medicine & genomic analysis 177
8.3.1.1.1 Advantages such as accurate disease predictions and improved outcomes to drive demand 177
8.3.1.2 Predictive models for treatment response 178
8.3.1.2.1 Ability to personalize therapies, improve outcomes, and minimize adverse effects to fuel growth 178
8.3.1.3 Treatment recommendation systems 179
8.3.1.3.1 Optimized healthcare delivery associated with treatment recommendation systems to support growth 179
8.3.2 PHARMACOLOGICAL THERAPY 180
8.3.2.1 Drug response prediction 181
8.3.2.1.1 Growth in use of drug response prediction to minimize adverse reactions to drive segment 181
8.3.2.2 Dosing & administration 181
8.3.2.2.1 Improved efficacy with highly personalized administration care to fuel adoption 181
8.3.2.3 Other pharmacological therapy functions 182
8.3.3 SURGICAL THERAPY 183
8.3.3.1 Preoperative imaging & 3D modeling 184
8.3.3.1.1 Enhanced surgical planning and precision to propel market 184
8.3.3.2 Intraoperative guidance & robotics 184
8.3.3.2.1 Faster recovery time post surgery to boost adoption 184
8.3.3.3 Postoperative analysis & recovery 185
8.3.3.3.1 Reduced complications with real-time monitoring to drive market 185
8.3.4 RADIATION THERAPY 186
8.3.4.1 Motion synchronization & auto contouring 187
8.3.4.1.1 Optimized radiation therapy with motion synchronization & auto contouring to boost market 187
8.3.4.2 Real-time adaptive treatment delivery 188
8.3.4.2.1 Reduced side effects with effective adaptive treatment to propel demand 188
8.3.4.3 Response assessment & quality assurance 188
8.3.4.3.1 Ability of AI to enhance response assessment and QA to spur growth 188
8.3.4.4 Other radiation therapy functions 189
8.3.5 BEHAVIORAL THERAPY & PSYCHOTHERAPY 190
8.3.5.1 Virtual counseling & chatbots 191
8.3.5.1.1 Ability to engage patients remotely to drive market demand 191
8.3.5.2 Progress monitoring & feedback 191
8.3.5.2.1 Increasing use of smart wearables and mobile health apps to drive market 191
8.3.5.3 Follow-up & long-term support 192
8.3.5.3.1 Widespread adoption of telemedicine platforms to drive market demand 192
8.3.6 IMMUNOTHERAPY 193
8.3.6.1 Real-time patient data monitoring 194
8.3.6.1.1 Need for real-time data analysis to make informed decisions to boost market growth 194
8.3.6.2 Response & side-effect prediction 195
8.3.6.2.1 Ability to reduce trial-and-error approach in medical treatments to drive segmental growth 195
8.3.6.3 Relapse prediction & long-term management 195
8.3.6.3.1 Need for proactive approach for long-term care to fuel market growth 195
8.3.7 OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS 196
8.4 PATIENT ENGAGEMENT & REMOTE MONITORING 197
8.4.1 SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE 198
8.4.1.1 Rising prevalence of chronic diseases to drive market growth 198
8.4.2 TELEHEALTH & REMOTE PATIENT MONITORING 199
8.4.2.1 Ability to monitor and evaluate patients remotely to boost market demand 199
8.4.3 HEALTHCARE ASSISTANCE ROBOTS 199
8.4.3.1 Advancements in robotics and artificial intelligence (AI) to boost market demand 199
8.4.4 MEDICATION REMINDERS 200
8.4.4.1 Increasing adoption of smartphone applications and IoT devices to surge market demand 200
8.4.5 PATIENT EDUCATION & EMPOWERMENT 201
8.4.5.1 Need to improve treatment adherence and enhance self-management to drive market growth 201
8.4.6 OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS 202
8.5 POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE 203
8.5.1 RECURRENCE MONITORING 204
8.5.1.1 Need to predict recurrence of cancer to drive market 204
8.5.2 LONG-TERM OUTCOME PREDICTION 204
8.5.2.1 Ability to predict long-term health outcomes and enhance patient care to drive market 204
8.5.3 MENTAL HEALTH & SUPPORT SYSTEMS 205
8.5.3.1 Need to help patients cope with mental strain to drive market 205
8.6 PHARMACY MANAGEMENT 206
8.6.1 EPRESCRIBING 207
8.6.1.1 Need to improve safety and efficiency in prescription to drive market 207
8.6.2 MEDICATION MANAGEMENT 207
8.6.2.1 Ability to predict adverse drug reactions by patient data analysis to drive market 207
8.6.3 PHARMACY AUDIT & ANALYSIS 208
8.6.3.1 Need for effective and efficient operation of pharmacies to drive market 208
8.6.4 OTHER PHARMACY MANAGEMENT FUNCTIONS 209
8.7 DATA MANAGEMENT & ANALYTICS 210
8.7.1 ABILITY OF DATA MANAGEMENT & ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS MAKE INFORMED DECISIONS TO BOOST MARKET 210
8.8 ADMINISTRATIVE 210
8.8.1 PATIENT REGISTRATION & SCHEDULING 212
8.8.1.1 Need to optimize patient registration process for smoother operations to drive market 212
8.8.2 PATIENT ELIGIBILITY & AUTHORIZATION 213
8.8.2.1 Need to reduce administrative burden to drive market 213
8.8.3 BILLING & CLAIMS MANAGEMENT 214
8.8.3.1 Need to make billing process more accurate, efficient, and transparent to drive market 214
8.8.4 WORKFORCE MANAGEMENT 215
8.8.4.1 Need for effective staff management to drive market 215
8.8.5 SUPPLY CHAIN & INVENTORY MANAGEMENT 216
8.8.5.1 Ability to make better procurement decisions to fuel market 216
8.8.6 COMPLIANCE & DOCUMENTATION 217
8.8.6.1 Need to reduce manual paperwork and errors to drive market 217
8.8.7 HEALTHCARE WORKFLOW MANAGEMENT 218
8.8.7.1 Need to optimize and automate processes within healthcare facilities to drive market 218
8.8.8 ASSET MANAGEMENT 219
8.8.8.1 Ability to optimize use and allocation of resources to drive market 219
8.8.9 CUSTOMER RELATIONSHIP MANAGEMENT 220
8.8.9.1 Enhancing patient engagement and retention through AI-driven CRM systems to boost market 220
8.8.10 FRAUD DETECTION & RISK MANAGEMENT 221
8.8.10.1 Need to enhance security in healthcare systems to drive market demand 221
8.8.11 CYBERSECURITY 222
8.8.11.1 Enhancing healthcare cybersecurity with AI-driven threat detection and risk management to fuel growth 222
8.8.12 OTHER ADMINISTRATIVE FUNCTIONS 223
9 AI IN HEALTHCARE MARKET, BY APPLICATION 224
9.1 INTRODUCTION 225
9.2 CLINICAL APPLICATIONS 225
9.2.1 ABILITY OF AI TO IMPROVE DIAGNOSTICS, TREATMENT, AND PATIENT CARE TO DRIVE MARKET GROWTH 225
9.3 NON-CLINICAL APPLICATIONS 227
9.3.1 ABILITY OF AI TO REDUCE ADMINISTRATIVE BURDEN AND ENSURE BETTER RESOURCE ALLOCATION TO FUEL GROWTH 227
10 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL 229
10.1 INTRODUCTION 230
10.2 ON-PREMISE MODELS 230
10.2.1 ENHANCED DATA SECURITY AND COMPLIANCE TO PROPEL ADOPTION OF ON-PREMISE AI MODELS 230
10.3 CLOUD-BASED MODELS 231
10.3.1 SCALABILITY AND AUTOMATION OF CLOUD-BASED AI PLATFORMS TO RESHAPE HEALTHCARE DELIVERY GLOBALLY 231
10.4 HYBRID MODELS 233
10.4.1 FLEXIBILITY FOR DIVERSE APPLICATIONS TO BOOST DEMAND FOR HYBRID MODELS 233
?
11 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TOOL 234
11.1 INTRODUCTION 235
11.2 MACHINE LEARNING 235
11.2.1 DEEP LEARNING 237
11.2.1.1 Convolutional neural networks (CNN) 239
11.2.1.1.1 Growing demand for advance medical imaging and diagnostics to drive market growth 239
11.2.1.2 Recurrent neural networks (RNN) 240
11.2.1.2.1 Ability of RNN to enhance predictive analytics in healthcare to boost market 240
11.2.1.3 Generative adversarial networks (GAN) 240
11.2.1.3.1 Ability to transform data scarcity and privacy in AI-driven healthcare to drive demand for GAN 240
11.2.1.4 Graph neural networks (GNN) 241
11.2.1.4.1 Ability of GNN to revolutionize relational insights in healthcare analytics to fuel growth 241
11.2.1.5 Other deep learning tools 242
11.2.2 SUPERVISED LEARNING 242
11.2.2.1 Need to drive precision and efficiency in healthcare to support adoption of supervised learning tools 242
11.2.3 REINFORCEMENT LEARNING 243
11.2.3.1 Wide usage of reinforcement learning models for real-time and adaptive healthcare solutions to support market growth 243
11.2.4 UNSUPERVISED LEARNING 244
11.2.4.1 Ability of unsupervised learning to drive innovation in healthcare analytics to propel market 244
11.2.5 OTHER MACHINE LEARNING TOOLS 245
11.3 NATURAL LANGUAGE PROCESSING (NLP) 246
11.3.1 SENTIMENT ANALYSIS 247
11.3.1.1 Enhanced patient experience and operational insights to spur demand for sentiment analysis 247
11.3.2 PATTERN & IMAGE RECOGNITION 248
11.3.2.1 Increased precision in clinical decision-making associated with pattern & image recognition to aid market 248
11.3.3 AUTO CODING 248
11.3.3.1 Advantages such as improved medical billing and administrative efficiency to boost market 248
11.3.4 CLASSIFICATION & CATEGORIZATION 249
11.3.4.1 Ability of classification & categorization to organize healthcare data for better outcomes to propel market 249
11.3.5 TEXT ANALYTICS 250
11.3.5.1 Ability to transform unstructured data into actionable healthcare insights to fuel growth 250
11.3.6 SPEECH RECOGNITION 250
11.3.6.1 Improved speech recognition advancing real-time documentation and accessibility to drive demand 250
11.4 CONTEXT-AWARE COMPUTING 251
11.4.1 DEVICE CONTEXT 252
11.4.1.1 Real-time monitoring and decision-making to contribute to market growth 252
11.4.2 USER CONTEXT 253
11.4.2.1 Personalized healthcare and adaptive workflows to drive demand 253
11.4.3 PHYSICAL CONTEXT 254
11.4.3.1 Location-based services associated with physical context to generate demand 254
11.5 GENERATIVE AI 255
11.5.1 ABILITY OF GENERATIVE AI MODELS TO MIMIC DISEASE PROGRESSION TO DRIVE MARKET 255
11.6 COMPUTER VISION 256
11.6.1 ABILITY TO DETECT ABNORMALITIES SUCH AS TUMORS TO FUEL ADOPTION 256
11.7 IMAGE ANALYSIS 257
11.7.1 NEED TO STREAMLINE DOCUMENT MANAGEMENT TO PROPEL MARKET 257
12 AI IN HEALTHCARE MARKET, BY END USER 259
12.1 INTRODUCTION 260
12.2 HEALTHCARE PROVIDERS 260
12.2.1 HOSPITALS & CLINICS 263
12.2.1.1 Growing need to improve profitability of healthcare to drive use of AI-based healthcare solutions in hospitals 263
12.2.2 AMBULATORY CARE CENTERS 264
12.2.2.1 Supportive government norms and incentives for HCIT solutions and services to drive market growth 264
12.2.3 HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES 265
12.2.3.1 Growing need for long-term home care to drive market growth 265
12.2.4 DIAGNOSTIC & IMAGING CENTERS 266
12.2.4.1 Growing burden of various chronic diseases to propel market growth 266
12.2.5 PHARMACIES 268
12.2.5.1 Advantages of workflow improvements and error reduction to drive AI-based healthcare solution adoption in pharmacies 268
12.2.6 OTHER HEALTHCARE PROVIDERS 269
12.3 HEALTHCARE PAYERS 269
12.3.1 PUBLIC PAYERS 270
12.3.1.1 Focus on developing outcome-based payment models to drive demand for payer solutions 270
12.3.2 PRIVATE PAYERS 271
12.3.2.1 Possible increases in operational efficiency to boost demand among private payers 271
?
12.4 PATIENTS 272
12.4.1 RISE IN USE OF AI IN MENTAL HEALTH SUPPORT APPLICATIONS THROUGH CHATBOTS AND VIRTUAL THERAPISTS TO BOOST MARKET 272
12.5 OTHER END USERS 273
13 AI IN HEALTHCARE MARKET, BY REGION 275
13.1 INTRODUCTION 276
13.2 NORTH AMERICA 277
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 279
13.2.2 US 293
13.2.2.1 Rising adoption of advanced medical imaging and regulatory support to drive market 293
13.2.3 CANADA 307
13.2.3.1 Growing burden of chronic diseases and availability of research grants for AI to drive market growth 307
13.3 EUROPE 321
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 321
13.3.2 GERMANY 335
13.3.2.1 Advanced healthcare system and government efforts to drive growth 335
13.3.3 UK 348
13.3.3.1 Government support and new AI platform emergence to boost market 348
13.3.4 FRANCE 360
13.3.4.1 Thriving AI ecosystem and strategic partnerships to boost healthcare innovation 360
13.3.5 ITALY 374
13.3.5.1 Regulatory reforms, strategic investments, and aging population to propel growth 374
13.3.6 SPAIN 388
13.3.6.1 Established network of research centers to propel market 388
13.3.7 REST OF EUROPE 402
13.4 ASIA PACIFIC 416
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 418
13.4.2 CHINA 432
13.4.2.1 Expanding AI applications in medical imaging and diagnostics to drive market growth 432
13.4.3 JAPAN 445
13.4.3.1 Strong healthcare infrastructure to drive uptake of advanced AI 445
13.4.4 INDIA 458
13.4.4.1 Favorable government initiatives for R&D investments to drive market 458
13.4.5 REST OF ASIA PACIFIC 471
13.5 LATIN AMERICA 483
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 484
13.5.2 BRAZIL 497
13.5.2.1 AI initiatives to drive healthcare innovation and accessibility 497
13.5.3 MEXICO 508
13.5.3.1 AI to revolutionize healthcare delivery and outcomes, focusing on accessibility, efficiency, and innovation 508
13.5.4 REST OF LATIN AMERICA 521
13.6 MIDDLE EAST & AFRICA 533
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 534
13.6.2 GCC COUNTRIES 547
13.6.2.1 AI-driven innovations and rise in healthcare investments to propel market growth 547
13.6.3 REST OF THE MIDDLE EAST & AFRICA 561
14 COMPETITIVE LANDSCAPE 574
14.1 INTRODUCTION 574
14.2 KEY PLAYER STRATEGY/RIGHT TO WIN 574
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET 575
14.3 REVENUE ANALYSIS, 2020-2024 578
14.4 MARKET SHARE ANALYSIS, 2024 579
14.4.1 RANKING OF KEY MARKET PLAYERS 582
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 583
14.5.1 STARS 583
14.5.2 EMERGING LEADERS 583
14.5.3 PERVASIVE PLAYERS 583
14.5.4 PARTICIPANTS 583
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 585
14.5.5.1 Company footprint 585
14.5.5.2 Regional footprint 586
14.5.5.3 Application footprint 587
14.5.5.4 Tool footprint 588
14.5.5.5 Function footprint 589
14.5.5.6 Offering footprint 590
14.5.5.7 Deployment footprint 591
14.5.5.8 End-user footprint 592
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 593
14.6.1 PROGRESSIVE COMPANIES 593
14.6.2 RESPONSIVE COMPANIES 593
14.6.3 DYNAMIC COMPANIES 593
14.6.4 STARTING BLOCKS 593
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 595
14.6.5.1 Detailed list of key startups/SMEs 595
14.6.5.2 Company footprint (startups/SMEs) 596
?
14.7 COMPANY VALUATION AND FINANCIAL METRICS 596
14.7.1 FINANCIAL METRICS 596
14.7.2 COMPANY VALUATION 597
14.8 BRAND/PRODUCT COMPARISON 598
14.9 COMPETITIVE SCENARIO 599
14.9.1 PRODUCT LAUNCHES 599
14.9.2 DEALS 600
14.9.3 OTHER DEVELOPMENTS 601
15 COMPANY PROFILES 603
15.1 KEY PLAYERS 603
15.1.1 KONINKLIJKE PHILIPS N.V. 603
15.1.1.1 Business overview 603
15.1.1.2 Products & services offered 604
15.1.1.3 Recent developments 607
15.1.1.3.1 Product launches 607
15.1.1.3.2 Deals 608
15.1.1.3.3 Expansions 610
15.1.1.3.4 Other developments 611
15.1.1.4 MnM view 611
15.1.1.4.1 Right to win 611
15.1.1.4.2 Strategic choices 612
15.1.1.4.3 Weaknesses & competitive threats 612
15.1.2 MICROSOFT CORPORATION 613
15.1.2.1 Business overview 613
15.1.2.2 Products & services offered 615
15.1.2.3 Recent developments 616
15.1.2.3.1 Product launches 616
15.1.2.3.2 Deals 617
15.1.2.4 MnM view 619
15.1.2.4.1 Right to win 619
15.1.2.4.2 Strategic choices 619
15.1.2.4.3 Weaknesses & competitive threats 620
15.1.3 NVIDIA CORPORATION 620
15.1.3.1 Business overview 620
15.1.3.2 Products & services offered 621
15.1.3.3 Recent developments 622
15.1.3.3.1 Product launches 622
15.1.3.3.2 Deals 623
15.1.3.4 MnM view 624
15.1.3.4.1 Right to win 624
15.1.3.4.2 Strategic choices 624
15.1.3.4.3 Weaknesses & competitive threats 624
15.1.4 SIEMENS HEALTHINEERS AG 625
15.1.4.1 Business overview 625
15.1.4.2 Products & services offered 627
15.1.4.3 Recent developments 628
15.1.4.3.1 Product launches & enhancements 628
15.1.4.3.2 Deals 628
15.1.4.3.3 Other developments 630
15.1.4.4 MnM view 630
15.1.4.4.1 Right to win 630
15.1.4.4.2 Strategic choices 630
15.1.4.4.3 Weaknesses & competitive threats 631
15.1.5 GE HEALTHCARE 632
15.1.5.1 Business overview 632
15.1.5.2 Products & services offered 634
15.1.5.3 Recent developments 635
15.1.5.3.1 Deals 635
15.1.5.3.2 Other developments 636
15.1.5.4 MnM view 636
15.1.5.4.1 Right to win 636
15.1.5.4.2 Strategic choices 637
15.1.5.4.3 Weaknesses & competitive threats 637
15.1.6 EPIC SYSTEMS CORPORATION 638
15.1.6.1 Business overview 638
15.1.6.2 Products & services offered 638
15.1.6.3 Recent developments 639
15.1.6.3.1 Deals 639
15.1.7 ORACLE CORPORATION 640
15.1.7.1 Business overview 640
15.1.7.2 Products & services offered 641
15.1.7.3 Recent developments 642
15.1.7.3.1 Product launches 642
15.1.7.3.2 Deals 643
15.1.7.3.3 Expansions 644
15.1.8 VERADIGM INC. 645
15.1.8.1 Business overview 645
15.1.8.2 Products & services offered 646
15.1.8.3 Recent developments 647
15.1.8.3.1 Deals 647
?
15.1.9 AMAZON WEB SERVICES, INC. 648
15.1.9.1 Business overview 648
15.1.9.2 Products & services offered 649
15.1.9.3 Recent developments 650
15.1.9.3.1 Product launches 650
15.1.9.3.2 Deals 651
15.1.9.3.3 Expansions 652
15.1.10 MERATIVE 653
15.1.10.1 Business overview 653
15.1.10.2 Products & services offered 653
15.1.10.3 Recent developments 654
15.1.10.3.1 Product launches 654
15.1.10.3.2 Deals 654
15.1.11 IBM 655
15.1.11.1 Business overview 655
15.1.11.2 Products & services offered 656
15.1.11.3 Recent developments 657
15.1.11.3.1 Deals 657
15.1.12 MEDTRONIC 658
15.1.12.1 Business overview 658
15.1.12.2 Products & services offered 659
15.1.12.3 Recent developments 660
15.1.12.3.1 Product launches 660
15.1.12.3.2 Deals 661
15.1.13 GOOGLE 662
15.1.13.1 Business overview 662
15.1.13.2 Products & services offered 663
15.1.13.3 Recent developments 664
15.1.13.3.1 Product launches 664
15.1.13.3.2 Deals 665
15.1.13.3.3 Other developments 667
15.1.14 SOPHIA GENETICS 668
15.1.14.1 Business overview 668
15.1.14.2 Products & services offered 669
15.1.14.3 Recent developments 669
15.1.14.3.1 Product launches 669
15.1.14.3.2 Deals 670
15.1.14.3.3 Other developments 671
15.1.15 JOHNSON & JOHNSON SERVICES, INC. 672
15.1.15.1 Business overview 672
15.1.15.2 Products & services offered 673
15.1.15.3 Recent developments 674
15.1.15.3.1 Other developments 674
15.1.15.3.2 Deals 674
15.1.16 TEMPUS AI, INC. 675
15.1.16.1 Business overview 675
15.1.16.2 Products & services offered 676
15.1.16.3 Recent developments 677
15.1.16.3.1 Product launches 677
15.1.16.3.2 Deals 678
15.1.17 CONCERTAI 679
15.1.17.1 Business overview 679
15.1.17.2 Products & services offered 679
15.1.17.3 Recent developments 680
15.1.17.3.1 Product launches 680
15.1.17.3.2 Deals 681
15.1.18 SOLVENTUM CORPORATION 683
15.1.18.1 Business overview 683
15.1.18.2 Products & services offered 684
15.1.18.3 Recent developments 685
15.1.18.3.1 Deals 685
15.1.18.3.2 Other developments 685
15.1.19 COGNIZANT 686
15.1.19.1 Business overview 686
15.1.19.2 Products & services offered 688
15.1.19.3 Recent developments 688
15.1.19.3.1 Product launches 688
15.1.19.3.2 Deals 689
15.1.20 VIZ.AI, INC. 690
15.1.20.1 Business overview 690
15.1.20.2 Products & services offered 690
15.1.20.3 Recent developments 691
15.1.20.3.1 Product launches 691
15.1.20.3.2 Deals 692
15.1.20.3.3 Other developments 694
15.1.21 RIVERAIN TECHNOLOGIES 695
15.1.21.1 Business overview 695
15.1.21.2 Products & services offered 695
15.1.21.3 Recent developments 696
15.1.21.3.1 Deals 696
?
15.2 OTHER PLAYERS 697
15.2.1 QVENTUS 697
15.2.2 QURE.AI 698
15.2.3 ATOMWISE INC. 699
15.2.4 ENLITIC 700
15.2.5 SEGMED 700
16 APPENDIX 701
16.1 DISCUSSION GUIDE 701
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 708
16.3 CUSTOMIZATION OPTIONS 710
16.4 RELATED REPORTS 710
16.5 AUTHOR DETAILS 711

TABLE 1 INCLUSIONS & EXCLUSIONS 60
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 64
TABLE 3 STUDY ASSUMPTIONS 77
TABLE 4 AI IN HEALTHCARE MARKET: RISK ASSESSMENT 78
TABLE 5 AI IN HEALTHCARE MARKET: IMPACT ANALYSIS 90
TABLE 6 COMPANIES AND THEIR ROLES IN AI IN HEALTHCARE ECOSYSTEM 109
TABLE 7 KEY PATENTS IN AI IN HEALTHCARE MARKET 112
TABLE 8 AI IN HEALTHCARE MARKET: LIST OF CONFERENCES & EVENTS, 2025-2026 114
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 118
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 119
TABLE 12 NORTH AMERICA 120
TABLE 13 EUROPE 122
TABLE 14 ASIA PACIFIC 122
TABLE 15 MIDDLE EAST & AFRICA 123
TABLE 16 LATIN AMERICA 124
TABLE 17 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER'S
FIVE FORCES ANALYSIS 124
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 127
TABLE 19 KEY BUYING CRITERIA FOR TOP THREE END USERS 128
TABLE 20 UNMET NEEDS IN AI IN HEALTHCARE MARKET 129
TABLE 21 END-USER EXPECTATIONS IN AI IN HEALTHCARE MARKET 130
TABLE 22 US ADJUSTED RECIPROCAL TARIFF RATES 142
TABLE 23 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR AI IN REMOTE PATIENT MONITORING 143
TABLE 24 EXPECTED CHANGE IN PRICES AND LIKELY IMPACT ON END-USE MARKET DUE TO TARIFF IMPACT 144
TABLE 1 AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 148
TABLE 2 AI IN HEALTHCARE MARKET FOR INTEGRATED SOLUTIONS, BY REGION,
2023-2030 (USD MILLION) 149
TABLE 3 AI IN HEALTHCARE MARKET FOR NICHE/POINT SOLUTIONS, BY REGION,
2023-2030 (USD MILLION) 150
TABLE 4 AI IN HEALTHCARE MARKET FOR AI TECHNOLOGIES, BY REGION,
2023-2030 (USD MILLION) 151
TABLE 5 AI IN HEALTHCARE MARKET FOR SERVICES, BY REGION,
2023-2030 (USD MILLION) 152
TABLE 6 AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 154
TABLE 7 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 155
TABLE 8 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS,
BY REGION, 2023-2030 (USD MILLION) 155
TABLE 9 AI IN HEALTHCARE MARKET FOR PRE-SCREENING, BY REGION,
2023-2030 (USD MILLION) 156
TABLE 10 AI IN HEALTHCARE MARKET FOR IVD, BY REGION, 2023-2030 (USD MILLION) 157
TABLE 11 AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 157
TABLE 12 AI IN HEALTHCARE MARKET FOR IMMUNOASSAYS, BY REGION,
2023-2030 (USD MILLION) 158
TABLE 13 AI IN HEALTHCARE MARKET FOR CLINICAL CHEMISTRY, BY REGION,
2023-2030 (USD MILLION) 159
TABLE 14 AI IN HEALTHCARE MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION,
2023-2030 (USD MILLION) 159
TABLE 15 AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION) 160
TABLE 16 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS & INTERPRETATION,
BY REGION, 2023-2030 (USD MILLION) 161
TABLE 17 AI IN HEALTHCARE MARKET FOR BIOMARKER DISCOVERY & ANALYSIS,
BY REGION, 2023-2030 (USD MILLION) 161
TABLE 18 AI IN HEALTHCARE MARKET FOR OTHER IVD APPLICATIONS, BY REGION,
2023-2030 (USD MILLION) 162
TABLE 19 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY REGION,
2023-2030 (USD MILLION) 163
TABLE 20 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION,
2023-2030 (USD MILLION) 163
TABLE 21 AI IN HEALTHCARE MARKET FOR DISEASE INTERPRETATION & REPORT ANALYSIS, BY REGION, 2023-2030 (USD MILLION) 164
TABLE 22 AI IN HEALTHCARE MARKET FOR IMAGE CAPTIONING & ANNOTATION, BY REGION, 2023-2030 (USD MILLION) 165
TABLE 23 AI IN HEALTHCARE MARKET FOR IMAGE RECONSTRUCTION, BY REGION,
2023-2030 (USD MILLION) 165
TABLE 24 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING APPLICATIONS,
BY REGION, 2023-2030 (USD MILLION) 166
TABLE 25 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY,
2023-2030 (USD MILLION) 167
TABLE 26 AI IN HEALTHCARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI),
BY REGION, 2023-2030 (USD MILLION) 168
TABLE 27 AI IN HEALTHCARE MARKET FOR COMPUTED TOMOGRAPHY (CT),
BY REGION, 2023-2030 (USD MILLION) 169
TABLE 28 AI IN HEALTHCARE MARKET FOR X-RAY IMAGING, BY REGION,
2023-2030 (USD MILLION) 169
TABLE 29 AI IN HEALTHCARE MARKET FOR ULTRASOUND, BY REGION,
2023-2030 (USD MILLION) 170
TABLE 30 AI IN HEALTHCARE MARKET FOR NUCLEAR IMAGING (PET & SPECT),
BY REGION, 2023-2030 (USD MILLION) 171
TABLE 31 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING MODALITIES,
BY REGION, 2023-2030 (USD MILLION) 172
TABLE 32 AI IN HEALTHCARE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY REGION, 2023-2030 (USD MILLION) 173
TABLE 33 AI IN HEALTHCARE MARKET FOR DRUG ALLERGY ALERTING, BY REGION,
2023-2030 (USD MILLION) 174
TABLE 34 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2023-2030 (USD MILLION) 174
TABLE 35 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION) 175
TABLE 36 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2023-2030 (USD MILLION) 176
TABLE 37 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,
BY TYPE, 2023-2030 (USD MILLION) 176
TABLE 38 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,
BY REGION, 2023-2030 (USD MILLION) 177
TABLE 39 AI IN HEALTHCARE MARKET FOR PRECISION MEDICINE & GENOMIC ANALYSIS,
BY REGION, 2023-2030 (USD MILLION) 178
TABLE 40 AI IN HEALTHCARE MARKET FOR PREDICTIVE MODELS FOR TREATMENT RESPONSE, BY REGION, 2023-2030 (USD MILLION) 179
TABLE 41 AI IN HEALTHCARE MARKET FOR TREATMENT RECOMMENDATION SYSTEMS,
BY REGION, 2023-2030 (USD MILLION) 179
TABLE 42 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 180
TABLE 43 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY REGION, 2023-2030 (USD MILLION) 180
TABLE 44 AI IN HEALTHCARE MARKET FOR DRUG RESPONSE PREDICTION, BY REGION, 2023-2030 (USD MILLION) 181
TABLE 45 AI IN HEALTHCARE MARKET FOR DOSING & ADMINISTRATION, BY REGION,
2023-2030 (USD MILLION) 182
TABLE 46 AI IN HEALTHCARE MARKET FOR OTHER PHARMACOLOGICAL THERAPY FUNCTIONS, BY REGION, 2023-2030 (USD MILLION) 182
TABLE 47 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 183
TABLE 48 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY REGION,
2023-2030 (USD MILLION) 183
TABLE 49 AI IN HEALTHCARE MARKET FOR PREOPERATIVE IMAGING & 3D MODELING,
BY REGION, 2023-2030 (USD MILLION) 184
TABLE 50 AI IN HEALTHCARE MARKET FOR INTRAOPERATIVE GUIDANCE & ROBOTICS,
BY REGION, 2023-2030 (USD MILLION) 185
TABLE 51 AI IN HEALTHCARE MARKET FOR POSTOPERATIVE ANALYSIS & RECOVERY,
BY REGION, 2023-2030 (USD MILLION) 186
TABLE 52 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 186
TABLE 53 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY REGION,
2023-2030 (USD MILLION) 187
TABLE 54 AI IN HEALTHCARE MARKET FOR MOTION SYNCHRONIZATION & AUTO CONTOURING, BY REGION, 2023-2030 (USD MILLION) 187
TABLE 55 AI IN HEALTHCARE MARKET FOR REAL-TIME ADAPTIVE TREATMENT DELIVERY,
BY REGION, 2023-2030 (USD MILLION) 188
TABLE 56 AI IN HEALTHCARE MARKET FOR RESPONSE ASSESSMENT & QUALITY ASSURANCE, BY REGION, 2023-2030 (USD MILLION) 189
TABLE 57 AI IN HEALTHCARE MARKET FOR OTHER RADIATION THERAPY FUNCTIONS,
BY REGION, 2023-2030 (USD MILLION) 189
TABLE 58 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY,
BY TYPE, 2023-2030 (USD MILLION) 190
TABLE 59 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY,
BY REGION, 2023-2030 (USD MILLION) 190
TABLE 60 AI IN HEALTHCARE MARKET FOR VIRTUAL COUNSELING & CHATBOTS, BY REGION, 2023-2030 (USD MILLION) 191
TABLE 61 AI IN HEALTHCARE MARKET FOR PROGRESS MONITORING & FEEDBACK,
BY REGION, 2023-2030 (USD MILLION) 192
TABLE 62 AI IN HEALTHCARE MARKET FOR FOLLOW-UP & LONG-TERM SUPPORT,
BY REGION, 2023-2030 (USD MILLION) 193
TABLE 63 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 193
TABLE 64 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY REGION,
2023-2030 (USD MILLION) 194
TABLE 65 AI IN HEALTHCARE MARKET FOR REAL-TIME PATIENT DATA MONITORING,
BY REGION, 2023-2030 (USD MILLION) 194
TABLE 66 AI IN HEALTHCARE MARKET FOR RESPONSE & SIDE-EFFECT PREDICTION,
BY REGION, 2023-2030 (USD MILLION) 195
TABLE 67 AI IN HEALTHCARE MARKET FOR RELAPSE PREDICTION & LONG-TERM MANAGEMENT, BY REGION, 2023-2030 (USD MILLION) 196
TABLE 68 AI IN HEALTHCARE MARKET FOR OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2023-2030 (USD MILLION) 196
TABLE 69 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION) 197
TABLE 70 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2023-2030 (USD MILLION) 198
TABLE 71 AI IN HEALTHCARE MARKET FOR SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE, BY REGION, 2023-2030 (USD MILLION) 198
TABLE 72 AI IN HEALTHCARE MARKET FOR TELEHEALTH & REMOTE PATIENT MONITORING, BY REGION, 2023-2030 (USD MILLION) 199
TABLE 73 AI IN HEALTHCARE MARKET FOR HEALTHCARE ASSISTANCE ROBOTS,
BY REGION, 2023-2030 (USD MILLION) 200
TABLE 74 AI IN HEALTHCARE MARKET FOR MEDICATION REMINDERS, BY REGION,
2023-2030 (USD MILLION) 201
TABLE 75 AI IN HEALTHCARE MARKET FOR PATIENT EDUCATION & EMPOWERMENT,
BY REGION, 2023-2030 (USD MILLION) 202
TABLE 76 AI IN HEALTHCARE MARKET FOR OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2023-2030 (USD MILLION) 202
TABLE 77 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION) 203
TABLE 78 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY REGION, 2023-2030 (USD MILLION) 203
TABLE 79 AI IN HEALTHCARE MARKET FOR RECURRENCE MONITORING, BY REGION,
2023-2030 (USD MILLION) 204
TABLE 80 AI IN HEALTHCARE MARKET FOR LONG-TERM OUTCOME PREDICTION, BY REGION, 2023-2030 (USD MILLION) 205
TABLE 81 AI IN HEALTHCARE MARKET FOR MENTAL HEALTH & SUPPORT SYSTEMS,
BY REGION, 2023-2030 (USD MILLION) 205
TABLE 82 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 206
TABLE 83 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS,
BY REGION, 2023-2030 (USD MILLION) 206
TABLE 84 AI IN HEALTHCARE MARKET FOR EPRESCRIBING, BY REGION,
2023-2030 (USD MILLION) 207
TABLE 85 AI IN HEALTHCARE MARKET FOR MEDICATION MANAGEMENT, BY REGION,
2023-2030 (USD MILLION) 208
TABLE 86 AI IN HEALTHCARE MARKET FOR PHARMACY AUDIT & ANALYSIS, BY REGION, 2023-2030 (USD MILLION) 209
TABLE 87 AI IN HEALTHCARE MARKET FOR OTHER PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2023-2030 (USD MILLION) 209
TABLE 88 AI IN HEALTHCARE MARKET FOR DATA MANAGEMENT & ANALYTICS FUNCTIONS, BY REGION, 2023-2030 (USD MILLION) 210
TABLE 89 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE,
2023-2030 (USD MILLION) 211
TABLE 90 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY REGION,
2023-2030 (USD MILLION) 212
TABLE 91 AI IN HEALTHCARE MARKET FOR PATIENT REGISTRATION & SCHEDULING,
BY REGION, 2023-2030 (USD MILLION) 213
TABLE 92 AI IN HEALTHCARE MARKET FOR PATIENT ELIGIBILITY & AUTHORIZATION,
BY REGION, 2023-2030 (USD MILLION) 214
TABLE 93 AI IN HEALTHCARE MARKET FOR BILLING & CLAIMS MANAGEMENT, BY REGION, 2023-2030 (USD MILLION) 215
TABLE 94 AI IN HEALTHCARE MARKET FOR WORKFORCE MANAGEMENT, BY REGION,
2023-2030 (USD MILLION) 216
TABLE 95 AI IN HEALTHCARE MARKET FOR SUPPLY CHAIN & INVENTORY MANAGEMENT,
BY REGION, 2023-2030 (USD MILLION) 217
TABLE 96 AI IN HEALTHCARE MARKET FOR COMPLIANCE & DOCUMENTATION,
BY REGION, 2023-2030 (USD MILLION) 218
TABLE 97 AI IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW MANAGEMENT,
BY REGION, 2023-2030 (USD MILLION) 219
TABLE 98 AI IN HEALTHCARE MARKET FOR ASSET MANAGEMENT, BY REGION,
2023-2030 (USD MILLION) 220
TABLE 99 AI IN HEALTHCARE MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT,
BY REGION, 2023-2030 (USD MILLION) 221
TABLE 100 AI IN HEALTHCARE MARKET FOR FRAUD DETECTION & RISK MANAGEMENT,
BY REGION, 2023-2030 (USD MILLION) 222
TABLE 101 AI IN HEALTHCARE MARKET FOR CYBERSECURITY, BY REGION,
2023-2030 (USD MILLION) 223
TABLE 102 AI IN HEALTHCARE MARKET FOR OTHER ADMINISTRATIVE FUNCTIONS,
BY REGION, 2023-2030 (USD MILLION) 223
TABLE 103 AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 225
TABLE 104 AI IN HEALTHCARE MARKET FOR CLINICAL APPLICATIONS, BY REGION, CAGR (2025-2030) 226
TABLE 105 AI IN HEALTHCARE MARKET FOR NON-CLINICAL APPLICATIONS, BY REGION,
2023-2030 (USD MILLION) 228
TABLE 106 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 230
TABLE 107 AI IN HEALTHCARE MARKET FOR ON-PREMISE MODELS, BY REGION,
2023-2030 (USD MILLION) 231
TABLE 108 AI IN HEALTHCARE MARKET FOR CLOUD-BASED MODELS, BY REGION,
2023-2030 (USD MILLION) 232
TABLE 109 AI IN HEALTHCARE MARKET FOR HYBRID MODELS, BY REGION,
CAGR (2025-2030) 233
TABLE 110 AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 235
TABLE 111 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 236
TABLE 112 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY REGION,
2023-2030 (USD MILLION) 237
TABLE 113 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 238
TABLE 114 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION,
2023-2030 (USD MILLION) 239
TABLE 115 AI IN HEALTHCARE MARKET FOR CONVOLUTIONAL NEURAL NETWORKS (CNN),
BY REGION, 2023-2030 (USD MILLION) 239
TABLE 116 AI IN HEALTHCARE MARKET FOR RECURRENT NEURAL NETWORKS (RNN),
BY REGION, 2023-2030 (USD MILLION) 240
TABLE 117 AI IN HEALTHCARE MARKET FOR GENERATIVE ADVERSARIAL NETWORKS (GAN),
BY REGION, 2023-2030 (USD MILLION) 241
TABLE 118 AI IN HEALTHCARE MARKET FOR GRAPH NEURAL NETWORKS (GNN), BY REGION, 2023-2030 (USD MILLION) 241
TABLE 119 AI IN HEALTHCARE MARKET FOR OTHER DEEP LEARNING TOOLS, BY REGION, 2023-2030 (USD MILLION) 242
TABLE 120 AI IN HEALTHCARE MARKET FOR SUPERVISED LEARNING, BY REGION,
2023-2030 (USD MILLION) 243
TABLE 121 AI IN HEALTHCARE MARKET FOR REINFORCEMENT LEARNING, BY REGION,
2023-2030 (USD MILLION) 244
TABLE 122 AI IN HEALTHCARE MARKET FOR UNSUPERVISED LEARNING, BY REGION,
2023-2030 (USD MILLION) 245
TABLE 123 AI IN HEALTHCARE MARKET FOR OTHER MACHINE LEARNING TOOLS,
BY REGION, 2023-2030 (USD MILLION) 245
TABLE 124 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP),
BY TYPE, 2023-2030 (USD MILLION) 246
TABLE 125 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP),
BY REGION, 2023-2030 (USD MILLION) 247
TABLE 126 AI IN HEALTHCARE MARKET FOR SENTIMENT ANALYSIS, BY REGION,
2023-2030 (USD MILLION) 247
TABLE 127 AI IN HEALTHCARE MARKET FOR PATTERN & IMAGE RECOGNITION,
BY REGION, 2023-2030 (USD MILLION) 248
TABLE 128 AI IN HEALTHCARE MARKET FOR AUTO CODING, BY REGION,
2023-2030 (USD MILLION) 249
TABLE 129 AI IN HEALTHCARE MARKET FOR CLASSIFICATION & CATEGORIZATION, BY REGION, 2023-2030 (USD MILLION) 249
TABLE 130 AI IN HEALTHCARE MARKET FOR TEXT ANALYTICS, BY REGION,
2023-2030 (USD MILLION) 250
TABLE 131 AI IN HEALTHCARE MARKET FOR SPEECH RECOGNITION, BY REGION,
2023-2030 (USD MILLION) 251
TABLE 132 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE,
2023-2030 (USD MILLION) 252
TABLE 133 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY REGION, 2023-2030 (USD MILLION) 252
TABLE 134 AI IN HEALTHCARE MARKET FOR DEVICE CONTEXT, BY REGION,
2023-2030 (USD MILLION) 253
TABLE 135 AI IN HEALTHCARE MARKET FOR USER CONTEXT, BY REGION,
2023-2030 (USD MILLION) 254
TABLE 136 AI IN HEALTHCARE MARKET FOR PHYSICAL CONTEXT, BY REGION,
2023-2030 (USD MILLION) 255
TABLE 137 AI IN HEALTHCARE MARKET FOR GENERATIVE AI, BY REGION,
2023-2030 (USD MILLION) 256
TABLE 138 AI IN HEALTHCARE MARKET FOR COMPUTER VISION, BY REGION,
2023-2030 (USD MILLION) 257
TABLE 139 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS, BY REGION,
2023-2030 (USD MILLION) 258
TABLE 140 AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 260
TABLE 141 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2023-2030 (USD MILLION) 262
TABLE 142 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION,
2023-2030 (USD MILLION) 262
TABLE 143 AI IN HEALTHCARE MARKET FOR HOSPITALS, BY REGION,
2023-2030 (USD MILLION) 264
TABLE 144 AI IN HEALTHCARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023-2030 (USD MILLION) 265
TABLE 145 AI IN HEALTHCARE MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES, BY REGION, 2023-2030 (USD MILLION) 266
TABLE 146 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC & IMAGING CENTERS,
BY REGION, 2023-2030 (USD MILLION) 267
TABLE 147 AI IN HEALTHCARE MARKET FOR PHARMACIES, BY REGION,
2023-2030 (USD MILLION) 268
TABLE 148 AI IN HEALTHCARE MARKET FOR OTHER HEALTHCARE PROVIDERS,
BY REGION, 2023-2030 (USD MILLION) 269
TABLE 149 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023-2030 (USD MILLION) 270
TABLE 150 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION,
2023-2030 (USD MILLION) 270
TABLE 151 AI IN HEALTHCARE MARKET FOR PUBLIC PAYERS, BY REGION,
2023-2030 (USD MILLION) 271
TABLE 152 AI IN HEALTHCARE MARKET FOR PRIVATE PAYERS, BY REGION,
2023-2030 (USD MILLION) 272
TABLE 153 AI IN HEALTHCARE MARKET FOR PATIENTS, BY REGION,
2023-2030 (USD MILLION) 273
TABLE 154 AI IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION,
2023-2030 (USD MILLION) 274
TABLE 155 AI IN HEALTHCARE MARKET, BY REGION, 2023-2030 (USD MILLION) 276
TABLE 156 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 279
TABLE 157 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING,
2023-2030 (USD MILLION) 280
TABLE 158 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION,
2023-2030 (USD MILLION) 280
TABLE 159 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION) 281
TABLE 160 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 281
TABLE 161 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 282
TABLE 162 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2023-2030 (USD MILLION) 282
TABLE 163 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2023-2030 (USD MILLION) 283
TABLE 164 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 283
TABLE 165 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 284
TABLE 166 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION) 284
TABLE 167 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 285
TABLE 168 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 285
TABLE 169 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 286
TABLE 170 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,
BY TYPE, 2023-2030 (USD MILLION) 286
TABLE 171 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 287
TABLE 172 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 287
TABLE 173 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2023-2030 (USD MILLION) 288
TABLE 174 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION) 288
TABLE 175 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 289
TABLE 176 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 289
TABLE 177 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY TOOL,
2023-2030 (USD MILLION) 290
TABLE 178 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,
BY TYPE, 2023-2030 (USD MILLION) 290
TABLE 179 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,
BY TYPE, 2023-2030 (USD MILLION) 291
TABLE 180 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION) 291
TABLE 181 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION) 292
TABLE 182 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY END USER,
2023-2030 (USD MILLION) 292
TABLE 183 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023-2030 (USD MILLION) 293
TABLE 184 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023-2030 (USD MILLION) 293
TABLE 185 US: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 294
TABLE 186 US: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 295
TABLE 187 US: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2023-2030 (USD MILLION) 295
TABLE 188 US: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 296
TABLE 189 US: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 296
TABLE 190 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2023-2030 (USD MILLION) 296
TABLE 191 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY,
2023-2030 (USD MILLION) 297
TABLE 192 US: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 297
TABLE 193 US: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,
BY TYPE, 2023-2030 (USD MILLION) 298
TABLE 194 US: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 298
TABLE 195 US: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 298
TABLE 196 US: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 299
TABLE 197 US: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 299
TABLE 198 US: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 300
TABLE 199 US: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 300
TABLE 200 US: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 301
TABLE 201 US: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE,
2023-2030 (USD MILLION) 301
TABLE 202 US: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 302
TABLE 203 US: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 302
TABLE 204 US: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 303
TABLE 205 US: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 303
TABLE 206 US: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 304
TABLE 207 US: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 304
TABLE 208 US: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2023-2030 (USD MILLION) 305
TABLE 209 US: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION) 305
TABLE 210 US: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 306
TABLE 211 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2023-2030 (USD MILLION) 306
TABLE 212 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023-2030 (USD MILLION) 307
TABLE 213 CANADA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 308
TABLE 214 CANADA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 308
TABLE 215 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2023-2030 (USD MILLION) 309
TABLE 216 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 309
TABLE 217 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 310
TABLE 218 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION) 310
TABLE 219 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION) 311
TABLE 220 CANADA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 311
TABLE 221 CANADA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 312
TABLE 222 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 312
TABLE 223 CANADA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 313
TABLE 224 CANADA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 313
TABLE 225 CANADA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 314
TABLE 226 CANADA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,
BY TYPE, 2023-2030 (USD MILLION) 314
TABLE 227 CANADA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 315
TABLE 228 CANADA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 315
TABLE 229 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2023-2030 (USD MILLION) 316
TABLE 230 CANADA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 316
TABLE 231 CANADA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 317
TABLE 232 CANADA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 317
TABLE 233 CANADA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 317
TABLE 234 CANADA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 318
TABLE 235 CANADA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 318
TABLE 236 CANADA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2023-2030 (USD MILLION) 319
TABLE 237 CANADA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2023-2030 (USD MILLION) 319
TABLE 238 CANADA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 320
TABLE 239 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023-2030 (USD MILLION) 320
TABLE 240 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023-2030 (USD MILLION) 320
TABLE 241 EUROPE: AI IN HEALTHCARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 322
TABLE 242 EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 322
TABLE 243 EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 323
TABLE 244 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2023-2030 (USD MILLION) 323
TABLE 245 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 324
TABLE 246 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 324
TABLE 247 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION) 324
TABLE 248 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION) 325
TABLE 249 EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 325
TABLE 250 EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 326
TABLE 251 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 326
TABLE 252 EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 327
TABLE 253 EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 327
TABLE 254 EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 328
TABLE 255 EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 328
TABLE 256 EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 329
TABLE 257 EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 329
TABLE 258 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION) 330
TABLE 259 EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 330
TABLE 260 EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 331
TABLE 261 EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 331
TABLE 262 EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 331
TABLE 263 EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 332
TABLE 264 EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 332
TABLE 265 EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2023-2030 (USD MILLION) 333
TABLE 266 EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2023-2030 (USD MILLION) 333
TABLE 267 EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 334
TABLE 268 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023-2030 (USD MILLION) 334
TABLE 269 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023-2030 (USD MILLION) 335
TABLE 270 GERMANY: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 336
TABLE 271 GERMANY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 336
TABLE 272 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2023-2030 (USD MILLION) 337
TABLE 273 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 337
TABLE 274 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 338
TABLE 275 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2023-2030 (USD MILLION) 338
TABLE 276 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION) 339
TABLE 277 GERMANY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 339
TABLE 278 GERMANY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 340
TABLE 279 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 340
TABLE 280 GERMANY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 340
TABLE 281 GERMANY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 341
TABLE 282 GERMANY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 341
TABLE 283 GERMANY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 341
TABLE 284 GERMANY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 342
TABLE 285 GERMANY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 342
TABLE 286 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2023-2030 (USD MILLION) 343
TABLE 287 GERMANY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 343
TABLE 288 GERMANY: AI IN HEALTHCARE MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 344
TABLE 289 GERMANY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 344
TABLE 290 GERMANY: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 344
TABLE 291 GERMANY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 345
TABLE 292 GERMANY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 345
TABLE 293 GERMANY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION) 346
TABLE 294 GERMANY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2023-2030 (USD MILLION) 346
TABLE 295 GERMANY: AI IN HEALTHCARE MARKET, BY END USER,
2023-2030 (USD MILLION) 347
TABLE 296 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023-2030 (USD MILLION) 347
TABLE 297 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023-2030 (USD MILLION) 348
TABLE 298 UK: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 349
TABLE 299 UK: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 349
TABLE 300 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2023-2030 (USD MILLION) 350
TABLE 301 UK: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 350
TABLE 302 UK: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 351

TABLE 303 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION) 351
TABLE 304 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY,
2023-2030 (USD MILLION) 352
TABLE 305 UK: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 352
TABLE 306 UK: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,
BY TYPE, 2023-2030 (USD MILLION) 353
TABLE 307 UK: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 353
TABLE 308 UK: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 353
TABLE 309 UK: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 354
TABLE 310 UK: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 354
TABLE 311 UK: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 354
TABLE 312 UK: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 355
TABLE 313 UK: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 355
TABLE 314 UK: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE,
2023-2030 (USD MILLION) 356
TABLE 315 UK: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION) 356
TABLE 316 UK: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 357
TABLE 317 UK: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 357
TABLE 318 UK: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 357
TABLE 319 UK: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 358
TABLE 320 UK: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 358
TABLE 321 UK: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2023-2030 (USD MILLION) 359
TABLE 322 UK: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2023-2030 (USD MILLION) 359
TABLE 323 UK: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 359
TABLE 324 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2023-2030 (USD MILLION) 360
TABLE 325 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023-2030 (USD MILLION) 360
TABLE 326 FRANCE: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 361
TABLE 327 FRANCE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 362
TABLE 328 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2023-2030 (USD MILLION) 362
TABLE 329 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 363
TABLE 330 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 363
TABLE 331 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION) 363
TABLE 332 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION) 364
TABLE 333 FRANCE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 364
TABLE 334 FRANCE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 365
TABLE 335 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION) 365
TABLE 336 FRANCE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 366
TABLE 337 FRANCE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 366
TABLE 338 FRANCE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 367
TABLE 339 FRANCE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 367
TABLE 340 FRANCE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 368
TABLE 341 FRANCE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 368
TABLE 342 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION) 369
TABLE 343 FRANCE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 369
TABLE 344 FRANCE: AI IN HEALTHCARE MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 370
TABLE 345 FRANCE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 370
TABLE 346 FRANCE: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 370
TABLE 347 FRANCE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 371
TABLE 348 FRANCE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 371
TABLE 349 FRANCE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2023-2030 (USD MILLION) 372
TABLE 350 FRANCE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2023-2030 (USD MILLION) 372
TABLE 351 FRANCE: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 373
TABLE 352 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023-2030 (USD MILLION) 373
TABLE 353 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023-2030 (USD MILLION) 373
TABLE 354 ITALY: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 375
TABLE 355 ITALY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 375
TABLE 356 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION) 376
TABLE 357 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 376
TABLE 358 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 377
TABLE 359 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2023-2030 (USD MILLION) 377
TABLE 360 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2023-2030 (USD MILLION) 378
TABLE 361 ITALY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 378
TABLE 362 ITALY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,
BY TYPE, 2023-2030 (USD MILLION) 379
TABLE 363 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 379
TABLE 364 ITALY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 380
TABLE 365 ITALY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 380
TABLE 366 ITALY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 381
TABLE 367 ITALY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 381
TABLE 368 ITALY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 382
TABLE 369 ITALY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 382
TABLE 370 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION) 383
TABLE 371 ITALY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION) 383
TABLE 372 ITALY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 384
TABLE 373 ITALY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 384
TABLE 374 ITALY: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 384
TABLE 375 ITALY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 385
TABLE 376 ITALY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 385
TABLE 377 ITALY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2023-2030 (USD MILLION) 386
TABLE 378 ITALY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2023-2030 (USD MILLION) 386
TABLE 379 ITALY: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 387
TABLE 380 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2023-2030 (USD MILLION) 387
TABLE 381 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023-2030 (USD MILLION) 388
TABLE 382 SPAIN: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 389
TABLE 383 SPAIN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 389
TABLE 384 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2023-2030 (USD MILLION) 390
TABLE 385 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 390
TABLE 386 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 391
TABLE 387 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2023-2030 (USD MILLION) 391
TABLE 388 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2023-2030 (USD MILLION) 392
TABLE 389 SPAIN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 392
TABLE 390 SPAIN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 393
TABLE 391 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 393
TABLE 392 SPAIN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 394
TABLE 393 SPAIN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 394
TABLE 394 SPAIN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 395
TABLE 395 SPAIN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 395
TABLE 396 SPAIN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 396
TABLE 397 SPAIN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 396
TABLE 398 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2023-2030 (USD MILLION) 397
TABLE 399 SPAIN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 397
TABLE 400 SPAIN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 398
TABLE 401 SPAIN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 398
TABLE 402 SPAIN: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 398
TABLE 403 SPAIN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 399
TABLE 404 SPAIN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 399
TABLE 405 SPAIN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2023-2030 (USD MILLION) 400
TABLE 406 SPAIN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2023-2030 (USD MILLION) 400
TABLE 407 SPAIN: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 401
TABLE 408 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION) 401
TABLE 409 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023-2030 (USD MILLION) 402
TABLE 410 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING,
2023-2030 (USD MILLION) 403
TABLE 411 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION,
2023-2030 (USD MILLION) 403
TABLE 412 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION) 404
TABLE 413 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 404
TABLE 414 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 405
TABLE 415 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2023-2030 (USD MILLION) 405
TABLE 416 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2023-2030 (USD MILLION) 406
TABLE 417 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 406
TABLE 418 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 407
TABLE 419 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION) 407
TABLE 420 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 408
TABLE 421 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 408
TABLE 422 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 409
TABLE 423 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 409
TABLE 424 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 410
TABLE 425 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 410
TABLE 426 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2023-2030 (USD MILLION) 411
TABLE 427 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION) 411
TABLE 428 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 412
TABLE 429 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 412
TABLE 430 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY TOOL,
2023-2030 (USD MILLION) 412
TABLE 431 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,
BY TYPE, 2023-2030 (USD MILLION) 413
TABLE 432 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,
BY TYPE, 2023-2030 (USD MILLION) 413
TABLE 433 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION) 414
TABLE 434 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION) 414
TABLE 435 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY END USER,
2023-2030 (USD MILLION) 415
TABLE 436 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023-2030 (USD MILLION) 415
TABLE 437 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023-2030 (USD MILLION) 415
TABLE 438 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 418
TABLE 439 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING,
2023-2030 (USD MILLION) 419
TABLE 440 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION,
2023-2030 (USD MILLION) 419
TABLE 441 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION) 420
TABLE 442 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 420
TABLE 443 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 421
TABLE 444 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2023-2030 (USD MILLION) 421
TABLE 445 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2023-2030 (USD MILLION) 422
TABLE 446 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 422
TABLE 447 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 423
TABLE 448 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 423
TABLE 449 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION) 424
TABLE 450 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2023-2030 (USD MILLION) 424
TABLE 451 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 425
TABLE 452 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 425
TABLE 453 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 426
TABLE 454 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 426
TABLE 455 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2023-2030 (USD MILLION) 427
TABLE 456 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 427
TABLE 457 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 428
TABLE 458 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 428
TABLE 459 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 429
TABLE 460 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,
BY TYPE, 2023-2030 (USD MILLION) 429
TABLE 461 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 430
TABLE 462 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION) 430
TABLE 463 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2023-2030 (USD MILLION) 431
TABLE 464 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER,
2023-2030 (USD MILLION) 431
TABLE 465 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023-2030 (USD MILLION) 432
TABLE 466 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023-2030 (USD MILLION) 432
TABLE 467 CHINA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 433
TABLE 468 CHINA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 434
TABLE 469 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2023-2030 (USD MILLION) 434
TABLE 470 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 435
TABLE 471 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 435
TABLE 472 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2023-2030 (USD MILLION) 435
TABLE 473 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2023-2030 (USD MILLION) 436
TABLE 474 CHINA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 436
TABLE 475 CHINA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 437
TABLE 476 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 437
TABLE 477 CHINA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 437
TABLE 478 CHINA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 438
TABLE 479 CHINA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 438
TABLE 480 CHINA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 438
TABLE 481 CHINA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 439
TABLE 482 CHINA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 439
TABLE 483 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2023-2030 (USD MILLION) 440
TABLE 484 CHINA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 440
TABLE 485 CHINA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 441
TABLE 486 CHINA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 441
TABLE 487 CHINA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 441
TABLE 488 CHINA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 442
TABLE 489 CHINA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 442
TABLE 490 CHINA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2023-2030 (USD MILLION) 443
TABLE 491 CHINA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2023-2030 (USD MILLION) 443
TABLE 492 CHINA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 444
TABLE 493 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023-2030 (USD MILLION) 444
TABLE 494 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023-2030 (USD MILLION) 445
TABLE 495 JAPAN: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 446
TABLE 496 JAPAN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 446
TABLE 497 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2023-2030 (USD MILLION) 447
TABLE 498 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 447
TABLE 499 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 448
TABLE 500 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2023-2030 (USD MILLION) 448
TABLE 501 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2023-2030 (USD MILLION) 449
TABLE 502 JAPAN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 449
TABLE 503 JAPAN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 450
TABLE 504 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 450
TABLE 505 JAPAN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 450
TABLE 506 JAPAN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 451
TABLE 507 JAPAN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 451
TABLE 508 JAPAN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 451
TABLE 509 JAPAN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 452
TABLE 510 JAPAN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 452
TABLE 511 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2023-2030 (USD MILLION) 453
TABLE 512 JAPAN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 453
TABLE 513 JAPAN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 454
TABLE 514 JAPAN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 454
TABLE 515 JAPAN: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 454
TABLE 516 JAPAN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,
BY TYPE, 2023-2030 (USD MILLION) 455
TABLE 517 JAPAN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 455
TABLE 518 JAPAN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2023-2030 (USD MILLION) 456
TABLE 519 JAPAN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION) 456
TABLE 520 JAPAN: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 457
TABLE 521 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION) 457
TABLE 522 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023-2030 (USD MILLION) 458
TABLE 523 INDIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2023-2030 (USD MILLION) 459
TABLE 524 INDIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION) 459
TABLE 525 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION) 460
TABLE 526 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2023-2030 (USD MILLION) 460
TABLE 527 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2023-2030 (USD MILLION) 461
TABLE 528 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2023-2030 (USD MILLION) 461
TABLE 529 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2023-2030 (USD MILLION) 462
TABLE 530 INDIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 462
TABLE 531 INDIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 463
TABLE 532 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 463
TABLE 533 INDIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2023-2030 (USD MILLION) 463
TABLE 534 INDIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2023-2030 (USD MILLION) 464
TABLE 535 INDIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 464
TABLE 536 INDIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2023-2030 (USD MILLION) 464
TABLE 537 INDIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 465
TABLE 538 INDIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 465
TABLE 539 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2023-2030 (USD MILLION) 466
TABLE 540 INDIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS,
BY TYPE, 2023-2030 (USD MILLION) 466
TABLE 541 INDIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 467
TABLE 542 INDIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2023-2030 (USD MILLION) 467
TABLE 543 INDIA: AI IN HEALTHCARE MARKET, BY TOOL, 2023-2030 (USD MILLION) 467
TABLE 544 INDIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2023-2030 (USD MILLION) 468
TABLE 545 INDIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2023-2030 (USD MILLION) 468
TABLE 546 INDIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2023-2030 (USD MILLION) 469
TABLE 547 INDIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION) 469
TABLE 548 INDIA: AI IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION) 469
TABLE 549 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2023-2030 (USD MILLION) 470
TABLE 550 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2023-2030 (USD MILLION) 470
TABLE 551 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING,
2023-2030 (USD MILLION) 471
TABLE 552 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION,
2023-2030 (USD MILLION) 472
TABLE 553 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2023-2030 (USD MILLION) 472
TABLE 554 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2023-2030 (USD MILLION) 473
TABLE 555 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2023-2030 (USD MILLION) 473
TABLE 556 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2023-2030 (USD MILLION) 473
TABLE 557 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2023-2030 (USD MILLION) 474
TABLE 558 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2023-2030 (USD MILLION) 474
TABLE 559 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2023-2030 (USD MILLION) 475
TABLE 560 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2023-2030 (USD MILLION) 475
TABLE 561 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 475
TABLE 562 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,
BY TYPE, 2023-2030 (USD MILLION) 476
TABLE 563 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2023-2030 (USD MILLION) 476
TABLE 564 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,
BY TYPE, 2023-2030 (USD MILLION) 476
TABLE 565 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2023-2030 (USD MILLION) 477
TABLE 566 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2023-2030 (USD MILLION) 477
TABLE 567 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION) 478
TABLE 568 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2023-2030 (USD MILLION) 478
TABLE 569 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 479
TABLE 570 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2023-2030 (USD MILLION) 479
TABLE 571 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL,
2023-2030 (USD MILLION) 479
TABLE 572 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,
BY TYPE, 2023-2030 (USD MILLION) 480
TABLE 573 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,
BY TYPE, 2023-2030 (USD MILLION) 480
TABLE 574 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2023-2030 (USD MILLION) 481
TABLE 575 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2023-2030 (USD MILLION) 481
TABLE 576 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER,
2023-2030 (USD MILLION) 482
TABLE 577 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION) 482
TABLE 578 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2023-2030 (USD MILLION) 483